HCWB HCW Biologics Inc
Company Analysis
Latest News
🟢 HCW Biologics is trading 10.82% up today as XBI gains 2.06%
HCW Biologics is trading at $2.56, up 10.82% today, with biotech-sector gains providing the clearest explanation; XBI is up 2.06% during regular trading. - No...
🟢 HCW Biologics is trading 8.23% up today as biotech shares strengthen broadly
HCW Biologics is trading now at $2.50, up 8.23%, as biotechnology shares strengthen broadly. - No new company-specific announcement dated August 25, 2026 was...
🟢 HCW Biologics is trading 5.5% up today; no clear catalyst identified
HCW Biologics is trading 5.5% up now at $2.30, with no clear company-specific announcement identified to explain the August 24, 2026 move. - The latest...
🟢 HCW Biologics is trading 11.27% up in pre-market
HCW Biologics is trading 11.27% up at $2.36 now, with no clear company-specific catalyst identified for August 21, 2026. - Its latest official release was the...
🟢 HCW Biologics is trading 8.49% up in pre-market with no clear catalyst identified
HCW Biologics is trading at $2.30 (+8.49%) in pre-market, with no reliable company-specific announcement identified to explain the August 21, 2026 rebound. -...
🟢 HCW Biologics is trading 5.66% up in after-hours trading; with no reliable company-specific explanation
HCW Biologics is trading 5.66% up at $2.24 after closing at $2.12 on August 20, 2026, with no reliable company-specific announcement explaining the after-hours...
🔴 HCW Biologics is trading 8.70% down today as biotech sector reverses prior-session rally
HCW Biologics is trading 8.70% down at $2.10 as the broader biotech sector reverses its prior-session rally. - XBI is down 2.47%, while the S&P 500, Nasdaq...
🟢 HCW Biologics rises 5.2% — Biotech Sector Surges on Positive mRNA Cancer Vaccine Trial Results
With Biotech (XBI) up 3.7%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, proxied by the XBI ETF, is trading...
🟢 HCW Biologics is trading 15.63% up in pre-market — no clear catalyst identified
HCW Biologics is trading 15.63% up at $2.46 after no clear August 19, 2026 company-specific catalyst was identified. - The latest major disclosure was the...
🟢 HCW Biologics is trading 10.80% up in after-hours trading despite no identified company-specific announcement
HCW Biologics is trading 10.80% up at $2.36 in after-hours trading, with no new company-specific announcement identified during the session. - Closed at $2.13...
🟢 HCW Biologics is trading 8.92% up in after-hours trading without a clear company-specific catalyst
HCW Biologics is trading 8.92% up at $2.32 in after-hours trading, with no major August 18 company-specific announcement clearly explaining the rebound. - It...
🔴 HCW Biologics is trading 13.89% down today after liquidity concerns
HCW Biologics is trading 13.89% down now at $2.17, extending declines after its August 14, 2026 second-quarter results raised funding and business-continuity...
🟢 HCW Biologics is trading 11.76% up today with no confirmed company-specific catalyst
HCW Biologics is trading $2.82 (+11.76%) with no verified company-specific announcement dated August 18, 2026 explaining the advance. - The latest confirmed...
🟢 HCW Biologics is trading 7.74% up today; catalyst remains unclear
HCW Biologics is trading 7.74% up at $2.71, rebounding from the August 17, 2026 close of $2.52 after several consecutive declines. - No new company-specific...
HCW Biologics Posts Widening Losses and Going-Concern Warning — Can This Biotech Survive Long Enough to Prove Its Science?
Shares of HCW Biologics plunged nearly 28% over the past week, falling from $3.17 to $2.28, after the clinical-stage biotech disclosed second-quarter results...
🔴 HCW Biologics is trading 9.69% down in pre-market after wider losses and going-concern doubt
HCW Biologics is trading 9.69% down at $2.28 after its August 14, 2026, second-quarter report highlighted a wider net loss and substantial doubt about...
🟢 HCW Biologics is trading 5.74% up in pre-market with no new company-specific announcement identified
HCW Biologics is trading at $2.66 (+5.74%) after closing at $2.52 on August 17, 2026; no new company-specific announcement was identified, and broader futures...
🔴 HCW Biologics is trading 5.78% down today after going-concern warning
HCW Biologics is trading 5.78% down now at $2.52 after investors continued reacting to the August 14, 2026 earnings release. - Second-quarter net loss widened...
HCW Biologics Inc Q2 2026 Earnings Preview: What Analysts Expect on August 17, 2026
Wall Street analysts expect HCW Biologics to report a net loss of $1.98 per share for the second quarter of 2026, while the stock currently trades at...
HCW Biologics second quarter 2026 loss hit $5.2M despite $6.7M year-to-date licensing revenue
HCW Biologics reported second quarter 2026 revenue of $0.14 million and a net loss of $5.2 million. While year-to-date performance was bolstered by a...